Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age

NCT01019772 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Infectious Disease by Haemophilus Influenzae Type b

Interventions

BIOLOGICAL: LBVH0101 (Hib vaccine)
BIOLOGICAL: Hiberix™ Vaccine

Sponsor

LG Life Sciences